← Leaderboards
Thomas Edward Prisinzano
University Of Iowa
$12,863,686
Attributed
$14,224,621
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,118,713 · 10
By mechanism
P20$10,177,560 · 6
R01$5,696,711 · 1
T32$2,352,986 · 1
R24$1,538,098 · 1
U01$1,353,358 · 1
Top collaborators
- Paul R. Hanson8 shared
- Audrey L Lamb3 shared
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseAnalogLeadEvaluationResearch PersonnelDesignIn VitroReportingPropertyBiologyPharmacologyInterestIn VivoPharmaceutical PreparationsStructureProgramsOpioidOpioid ReceptorLigandsModificationFundingInnovationGrantBiological
Grant awards (44)
Chem Core$383,592
P20 · FY2025 · GM · contact PI
Development of Agents for Synthetic Opioid Overdose$444,220
U01 · FY2023 · DA · contact PI
Development of Agents for Synthetic Opioid Overdose$450,138
U01 · FY2022 · DA · contact PI
Development of Agents for Synthetic Opioid Overdose$459,000
U01 · FY2021 · DA · contact PI
Investigation of Neoclerodanes as Novel Opioid Ligands$417,336
R01 · FY2020 · DA · contact PI
Investigation of Neoclerodanes as Novel Opioid Ligands$430,586
R01 · FY2019 · DA · contact PI
Chemical Biology of Infectious Disease$2,264,662
P20 · FY2018 · GM · contact PI
Investigation of Neoclerodanes as Novel Opioid Ligands$427,415
R01 · FY2018 · DA · contact PI
Chemical Biology of Infectious Disease$2,265,277
P20 · FY2017 · GM · contact PI
Administrative Core$920,556
P20 · FY2017 · GM · contact PI
Investigation of Neoclerodanes as Novel Opioid Ligands$436,907
R01 · FY2017 · DA · contact PI
Training Grant in Dynamic Aspects of Chemical Biology$372,892
T32 · FY2017 · GM · contact PI
Core C: Computational Chemical Biology$232,285
P20 · FY2017 · GM · contact PI
Core D: Medicinal Chemistry$226,366
P20 · FY2017 · GM · contact PI
Chemical Biology of Infectious Disease$2,364,153
P20 · FY2016 · GM · contact PI
Administrative Core$989,179
P20 · FY2016 · GM · contact PI
Investigation of Neoclerodanes as Novel Opioid Ligands$487,473
R01 · FY2016 · DA · contact PI
Legacy continuation of the KU CMLD Mission$480,539
R24 · FY2016 · GM · contact PI
Training Grant in Dynamic Aspects of Chemical Biology$368,849
T32 · FY2016 · GM · contact PI
Core C: Computational Chemical Biology$222,655
P20 · FY2016 · GM · contact PI
Core D: Medicinal Chemistry$216,065
P20 · FY2016 · GM · contact PI
Alteration and Renovation$92,770
P20 · FY2016 · GM · contact PI
Legacy continuation of the KU CMLD Mission$516,951
R24 · FY2015 · GM · contact PI
Training Grant in Dynamic Aspects of Chemical Biology$364,909
T32 · FY2015 · GM · contact PI
Legacy continuation of the KU CMLD Mission$540,608
R24 · FY2014 · GM · contact PI
Investigation of Neoclerodanes as Novel Opioid Ligands$341,342
R01 · FY2014 · DA · contact PI
Training Grant in Dynamic Aspects of Chemical Biology$222,140
T32 · FY2014 · GM
Investigation of Neoclerodanes as Novel Opioid Ligands$328,042
R01 · FY2013 · DA · contact PI
Training Grant in Dynamic Aspects of Chemical Biology$258,129
T32 · FY2013 · GM
Investigation of Neoclerodanes as Novel Opioid Ligands$342,060
R01 · FY2012 · DA · contact PI
Training Grant in Dynamic Aspects of Chemical Biology$258,129
T32 · FY2012 · GM
Investigation of Neoclerodanes as Novel Opioid Ligands$17,255
R01 · FY2012 · DA · contact PI
Investigation of Neoclerodanes as Novel Opioid Ligands$342,388
R01 · FY2011 · DA · contact PI
Training Grant in Dynamic Aspects of Chemical Biology$255,330
T32 · FY2011 · GM
Investigation of Neoclerodanes as Novel Opioid Ligands$365,048
R01 · FY2010 · DA · contact PI
Training Grant in Dynamic Aspects of Chemical Biology$252,608
T32 · FY2010 · GM
Investigation of Neoclerodanes as Novel Opioid Ligands$311,320
R01 · FY2009 · DA · contact PI
Investigation of Neoclerodanes as Novel Opioid Ligands$70,117
R01 · FY2009 · DA · contact PI
Investigation of Neoclerodanes as Novel Opioid Ligands$317,767
R01 · FY2008 · DA · contact PI
Investigation of Neoclerodanes as Novel Opioid Ligands$349,785
R01 · FY2007 · DA · contact PI
Investigation of Neoclerodanes as Novel Opioid Ligands$9,137
R01 · FY2007 · DA · contact PI
Investigation of Neoclerodanes as Novel Opioid Ligands$322,856
R01 · FY2006 · DA · contact PI
Investigation of Neoclerodanes as Novel Opioid Ligands$37,377
R01 · FY2006 · DA · contact PI
Investigation of Neoclerodanes as Novel Opioid Ligands$342,500
R01 · FY2005 · DA